I earned my BSc in Biology from the University of the Basque Country (UPV-EHU) in 2009. I started my research career in 2006 working as an undergraduate laboratory volunteer in the Department of Microbiology (UPV-EHU, 2006-2009), in fact, I received an Undergraduate Research Training Fellowship from the Spanish Ministry in 2008. Afterward, I completed a Master\\\'s Degree in Molecular Biology and Biomedicine (UPV-EHU, 2009-2010). In 2011, I received the Predoctoral Research Training Fellowship from UPV-EHU to develop my Doctoral Thesis about the morphofunctional changes in a 6-OHDA-induced rat model of Parkinson\\\'s disease (PD) and the effects of neurotrophic factors administration. In 2014, I received the Internship Research Training Fellowship granted by UPV-EHU to carry out an internship at Harvard Medical School (Boston, USA). During this stay, I assessed the role of the leucine-rich repeat kinase 2 (LRRK2) protein on the clearance of extracellular alpha-synuclein by microglia. In 2015, following the completion of my Doctorate with the highest honours \\\"Summa Cum Laude\\\" and with special mention as International PhD, I received the Extraordinary Doctorate Award from UPV-EHU. I have also participated in scientific divulgation appearing the results obtained in my Doctoral Thesis on national and international mass media. From November 2015 to July 2016, I was awarded a Research Training Fellowship from the UPV-EHU to perform a project based on the nanodelivery of neuroprotective drugs in a preclinical model of PD. In 2017, I worked as a research fellow at the School of Pharmacy (UPV-EHU, Vitoria) performing a project to test the effect of polyunsaturated fatty acids in animal models of PD. I was also working as a research fellow in the Neuropharmacology Research Group (UPV-EHU) in order to study the serotoninergic modulation of the basal ganglia in a severe model of PD. In 2017, I was awarded a postdoctoral fellowship from the Alfonso Martin Escudero Foundation to develop my postdoctoral training at the Icahn School of Medicine at Mount Sinai in New York from 2018 to 2019. During that time, I was the head of the research line based on studying the molecular and cellular mechanisms for autophagic clearance of alpha-synuclein. Afterward, I joined the Elekin Research (UPV/EHU)  to perform a project aimed to develop multisensory stimulation tools for Alzheimer\\\'s disease. From 2020 to 2022, I was working as a postdoctoral fellow at Cajal Institute participating in European and national projects related to the study of neuropathological bases of PD and therapeutic approaches. In 2023 I was working as a postdoctoral researcher in an international project at the Instituto Teófilo Hernando (UAM), which aims to test cholinergic compounds on several neurodegenerative conditions. I am currently working as a PhD Assistant Professor of cell biology and histology at CEU San Pablo University  (Madrid, Spain), where I will also develop my research projects. As part of my teaching and research career, I have also been a Lecturer of Master courses, and I have supervised various master theses. I have also prepared and participated in various research projects, and in several international and national congresses. Remarkably, I have 17 publications (5 as first author and as corresponding author) of which 13 are ranked in the Q1. I have been invited to give scientific seminars and oral presentations at international congresses, and I am actively collaborating with international centres. In summary, my research interest is focused on studying morpho- functional changes, and molecular and cellular mechanisms underlying neurodegenerative disorders to identify biomarkers and develop neuroprotective strategies.